Privia Health Group, Inc. Basic Shares Outstanding (Weighted Average)
Privia Health Group, Inc. (PRVA) reported Basic Shares Outstanding (Weighted Average) of 126.12 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- Privia Health Group, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 126.12M shares, a 3.27% increase year-over-year.
- Privia Health Group, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 124.15M shares, a 2.93% increase year-over-year.
- Privia Health Group, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 123.18M shares, a 2.53% increase year-over-year.
- Privia Health Group, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 122.77M shares, a 2.60% increase year-over-year.
- Privia Health Group, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 122.18M shares, a 2.32% increase from fiscal 2024.
- Privia Health Group, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 119.40M shares, a 2.29% increase from fiscal 2023.
- Privia Health Group, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 116.73M shares, a 5.45% increase from fiscal 2022.
- Privia Health Group, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 110.70M shares, a 7.52% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 126.12M shares 10-Q · filed 2026-08-06 | 125.14M shares 10-Q · filed 2026-08-06 | 124.49M shares derived: average of 3 quarters · filed 2026-08-06 | 124.06M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 124.15M shares 10-Q · filed 2026-05-07 | 123.67M shares derived: average of 2 quarters · filed 2026-05-07 | 123.37M shares derived: average of 3 quarters · filed 2026-05-07 | 123.06M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 123.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 122.98M shares derived: average of 2 quarters · filed 2026-02-27 | 122.70M shares derived: average of 3 quarters · filed 2026-08-06 | 122.18M shares 10-K · filed 2026-02-27 |
| 2025-09-30 | 122.77M shares 10-Q · filed 2025-11-06 | 122.45M shares derived: average of 2 quarters · filed 2026-08-06 | 121.84M shares 10-Q · filed 2025-11-06 | 121.42M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 122.13M shares 10-Q · filed 2026-08-06 | 121.37M shares 10-Q · filed 2026-08-06 | 120.97M shares derived: average of 3 quarters · filed 2026-08-06 | 120.64M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 120.62M shares 10-Q · filed 2026-05-07 | 120.38M shares derived: average of 2 quarters · filed 2026-05-07 | 120.14M shares derived: average of 3 quarters · filed 2026-05-07 | 119.93M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 120.14M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 119.90M shares derived: average of 2 quarters · filed 2026-02-27 | 119.70M shares derived: average of 3 quarters · filed 2026-02-27 | 119.40M shares 10-K · filed 2026-02-27 |
| 2024-09-30 | 119.66M shares 10-Q · filed 2025-11-06 | 119.48M shares derived: average of 2 quarters · filed 2025-11-06 | 119.16M shares 10-Q · filed 2025-11-06 | 118.90M shares derived: average of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | 119.30M shares 10-Q · filed 2025-08-07 | 118.90M shares 10-Q · filed 2025-08-07 | 118.64M shares derived: average of 3 quarters · filed 2026-02-27 | 118.38M shares derived: average of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | 118.51M shares 10-Q · filed 2025-05-08 | 118.32M shares derived: average of 2 quarters · filed 2026-02-27 | 118.08M shares derived: average of 3 quarters · filed 2026-02-27 | 117.60M shares derived: average of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | 118.12M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 117.86M shares derived: average of 2 quarters · filed 2026-02-27 | 117.30M shares derived: average of 3 quarters · filed 2026-02-27 | 116.73M shares 10-K · filed 2026-02-27 |
| 2023-09-30 | 117.60M shares 10-Q · filed 2024-11-07 | 116.88M shares derived: average of 2 quarters · filed 2024-11-07 | 116.27M shares 10-Q · filed 2024-11-07 | 115.79M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | 116.16M shares 10-Q · filed 2024-08-08 | 115.59M shares 10-Q · filed 2024-08-08 | 115.19M shares derived: average of 3 quarters · filed 2025-02-27 | 114.29M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | 115.01M shares 10-Q · filed 2024-05-09 | 114.71M shares derived: average of 2 quarters · filed 2025-02-27 | 113.67M shares derived: average of 3 quarters · filed 2025-02-27 | 112.42M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | 114.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 113.00M shares derived: average of 2 quarters · filed 2025-02-27 | 111.56M shares derived: average of 3 quarters · filed 2025-02-27 | 110.70M shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 111.59M shares 10-Q · filed 2023-11-03 | 110.14M shares derived: average of 2 quarters · filed 2023-11-03 | 109.46M shares 10-Q · filed 2023-11-03 | 108.85M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | 108.69M shares 10-Q · filed 2023-08-03 | 108.37M shares 10-Q · filed 2023-08-03 | 107.94M shares derived: average of 3 quarters · filed 2024-02-27 | 107.43M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | 108.06M shares 10-Q · filed 2023-05-04 | 107.57M shares derived: average of 2 quarters · filed 2024-02-27 | 107.01M shares derived: average of 3 quarters · filed 2024-02-27 | 105.94M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | 107.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 106.49M shares derived: average of 2 quarters · filed 2024-02-27 | 105.24M shares derived: average of 3 quarters · filed 2024-02-27 | 102.95M shares 10-K · filed 2024-02-27 |
| 2021-09-30 | 105.90M shares 10-Q · filed 2022-11-10 | 104.32M shares derived: average of 2 quarters · filed 2022-11-10 | 101.58M shares 10-Q · filed 2022-11-10 | 100.15M shares derived: average of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | 102.74M shares 10-Q · filed 2022-08-11 | 99.38M shares 10-Q · filed 2022-08-11 | 98.23M shares derived: average of 3 quarters · filed 2023-03-01 | 97.66M shares derived: average of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | 95.99M shares 10-Q · filed 2022-05-12 | 95.97M shares derived: average of 2 quarters · filed 2023-03-01 | 95.97M shares derived: average of 3 quarters · filed 2023-03-01 | 95.96M shares derived: average of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | 95.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 95.96M shares derived: average of 2 quarters · filed 2023-03-01 | 95.95M shares derived: average of 3 quarters · filed 2023-03-01 | 95.95M shares 10-K · filed 2023-03-01 |
| 2020-09-30 | 95.95M shares 10-Q · filed 2021-11-08 | 95.94M shares derived: average of 2 quarters · filed 2021-11-08 | 95.95M shares 10-Q · filed 2021-11-08 | |
| 2020-06-30 | 95.93M shares 10-Q · filed 2021-08-09 | 95.93M shares 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | 95.93M shares 10-Q · filed 2021-05-28 | |||
| 2019-12-31 | 95.93M shares 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |